2002
DOI: 10.1080/j.1600-0412.2002.810804.x
|View full text |Cite
|
Sign up to set email alerts
|

New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
33
1

Year Published

2007
2007
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(36 citation statements)
references
References 0 publications
2
33
1
Order By: Relevance
“…fFN false results can obtained in cases of amniotic fluid contamination, vaginal bleeding, and unprotected sexual intercourse [4]. IGFBP-1 belongs to the insulin-like binding proteins super-family, released into CVF during the process of the chorio-decidual disruption, and its detection in the CVF associated with increased risk of PTL [12] [13]. Clinical diagnostic trials indicate that fFN and phIGFBP1 are good negative predictors of PTL (92% specificity) with limited sensitivity, and PPVs in asymptomatic women [14].…”
Section: Introductionmentioning
confidence: 99%
“…fFN false results can obtained in cases of amniotic fluid contamination, vaginal bleeding, and unprotected sexual intercourse [4]. IGFBP-1 belongs to the insulin-like binding proteins super-family, released into CVF during the process of the chorio-decidual disruption, and its detection in the CVF associated with increased risk of PTL [12] [13]. Clinical diagnostic trials indicate that fFN and phIGFBP1 are good negative predictors of PTL (92% specificity) with limited sensitivity, and PPVs in asymptomatic women [14].…”
Section: Introductionmentioning
confidence: 99%
“…This was followed by many studies showing high sensitivity (70-80%) and negative predictive value (79-90%) of the test [8][9][10][11].…”
Section: Discussionmentioning
confidence: 99%
“…phIGFBP-1 test: positive (X10 mg l À1 ) versus negative (<10 mg l À1 ) test, as recommended by Lembet et al 11 and the manufacturer of the test (Medix Biochemica). fFN test: positive (X50 ng ml À1 ) versus negative (<50 ng ml À1 ), as defined by the manufacturer (Adeza Biomedical Corporation, Sunnyvale, CA, USA).…”
Section: Main Data Itemsmentioning
confidence: 99%
“…Nonetheless, available research suggested that a negative phIGFBP-1 test would rule out imminent delivery in B90 to 95% of patients. [7][8][9][10][11] The negative predictive value (NPV) of phIGFBP-1 was therefore felt to be comparable to fFN, although there was little evidence directly comparing the two tests in the same population. 12 Our prospective cohort study set out to examine the sensitivity, specificity, positive predictive value (PPV) and NPV of phIGFBP-1 test in predicting preterm delivery in women with symptoms of preterm labor.…”
Section: Introductionmentioning
confidence: 99%